These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36907081)

  • 1. Fifty years of research on status epilepticus: Seizures use hippocampal memory circuits to generate status epilepticus and disrupt brain development.
    Wasterlain C
    Epilepsy Behav; 2023 Apr; 141():109142. PubMed ID: 36907081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
    Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational polytherapy in the treatment of cholinergic seizures.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Suchomelova L; Naylor D; Estrada IBF; Schultz M; Furtado MA; Wasterlain CG
    Neurobiol Dis; 2020 Jan; 133():104537. PubMed ID: 31454548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel drugs and early polypharmacotherapy in status epilepticus.
    Amengual-Gual M; Sánchez Fernández I; Wainwright MS
    Seizure; 2019 May; 68():79-88. PubMed ID: 30473267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
    Niquet J; Baldwin R; Norman K; Suchomelova L; Lumley L; Wasterlain CG
    Epilepsia; 2016 Sep; 57(9):1406-15. PubMed ID: 27500978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational polytherapy in the treatment of acute seizures and status epilepticus.
    Wasterlain CG; Baldwin R; Naylor DE; Thompson KW; Suchomelova L; Niquet J
    Epilepsia; 2011 Oct; 52 Suppl 8(0 8):70-1. PubMed ID: 21967369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
    Löscher W
    Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous triple therapy for the treatment of status epilepticus.
    Niquet J; Baldwin R; Norman K; Suchomelova L; Lumley L; Wasterlain CG
    Neurobiol Dis; 2017 Aug; 104():41-49. PubMed ID: 28461248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the pathophysiology of status epilepticus.
    Chen JW; Naylor DE; Wasterlain CG
    Acta Neurol Scand Suppl; 2007; 186():7-15. PubMed ID: 17784531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of experimental status epilepticus with synergistic drug combinations.
    Niquet J; Baldwin R; Suchomelova L; Lumley L; Eavey R; Wasterlain CG
    Epilepsia; 2017 Apr; 58(4):e49-e53. PubMed ID: 28225161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
    Niquet J; Nguyen D; de Araujo Furtado M; Lumley L
    Epilepsia Open; 2023 May; 8 Suppl 1(Suppl 1):S117-S140. PubMed ID: 36807554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of AMPA receptors and their antagonists in status epilepticus.
    Leo A; Giovannini G; Russo E; Meletti S
    Epilepsia; 2018 Jun; 59(6):1098-1108. PubMed ID: 29663350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment.
    Niquet J; Baldwin R; Suchomelova L; Lumley L; Naylor D; Eavey R; Wasterlain CG
    Ann N Y Acad Sci; 2016 Aug; 1378(1):166-173. PubMed ID: 27392038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why ketamine.
    Coles L; Rosenthal ES; Bleck TP; Elm J; Zehtabchi S; Chamberlain J; Cloyd J; Shinnar S; Silbergleit R; Kapur J
    Epilepsy Behav; 2023 Apr; 141():109066. PubMed ID: 36609129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors.
    Lumley L; Niquet J; Marrero-Rosado B; Schultz M; Rossetti F; de Araujo Furtado M; Wasterlain C
    Neuropharmacology; 2021 Mar; 185():108444. PubMed ID: 33359073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model.
    Zhou R; Wang Y; Cao X; Li Z; Yu J
    Med Sci Monit; 2021 Dec; 27():e934043. PubMed ID: 34866132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for Pediatric Convulsive Status Epilepticus.
    Singh A; Stredny CM; Loddenkemper T
    CNS Drugs; 2020 Jan; 34(1):47-63. PubMed ID: 31879852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice.
    Marrero-Rosado BM; de Araujo Furtado M; Kundrick ER; Walker KA; Stone MF; Schultz CR; Nguyen DA; Lumley LA
    Epilepsy Behav; 2020 Oct; 111():107229. PubMed ID: 32575012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbital in Status epilepticus - Rediscovery of an effective drug.
    Trinka E
    Epilepsy Behav; 2023 Apr; 141():109104. PubMed ID: 36807987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of convulsive status epilepticus.
    Sánchez Fernández I; Goodkin HP; Scott RC
    Seizure; 2019 May; 68():16-21. PubMed ID: 30170734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.